Skip to main content
. 2016 Feb 17;13(4):3027–3035. doi: 10.3892/mmr.2016.4902

Figure 4.

Figure 4

FASN overexpression predicted a poor prognosis of GC. Staining scores for (A) FASN in postoperative recurrence of stages I–III patients with GC and (B) the mortality of stage IV patients with GC. (C) Kaplan-Meier curves for postoperative recurrence of stages I–III GC in relation to FASN expression. (D) Survival of stage IV patients analyzed in relation to FASN expression. FASN, fatty acid synthase; GC, gastric cancer.